An engineered CX3CR1 antagonist endowed with anti-inflammatory activity.
Dorgham K, Ghadiri A, Hermand P, Rodero M, Poupel L, Iga M, Hartley O, Gorochov G, Combadière C, Deterre P.
Dorgham K, et al. Among authors: combadiere c.
J Leukoc Biol. 2009 Oct;86(4):903-11. doi: 10.1189/jlb.0308158. Epub 2009 Jul 1.
J Leukoc Biol. 2009.
PMID: 19571253